Scleroderma: oral, maxillofacial and radiographic manifestations for dental practitioners.
Journal
British dental journal
ISSN: 1476-5373
Titre abrégé: Br Dent J
Pays: England
ID NLM: 7513219
Informations de publication
Date de publication:
Jun 2024
Jun 2024
Historique:
received:
13
11
2023
accepted:
14
02
2024
revised:
12
02
2024
medline:
15
6
2024
pubmed:
15
6
2024
entrez:
14
6
2024
Statut:
ppublish
Résumé
Scleroderma is an autoimmune condition of unknown aetiology with a range of manifestations, which can be limited to the skin or can extend to be multisystemic. It is characterised by fibrosis, microangiopathy and dysregulation of the immune system and commonly affects the oral cavity. Frequent oral and maxillofacial features include fibrosis of the face, circumoral furrows and reduced oral aperture. Radiographic findings are often incidental, including uniform, asymptomatic periodontal ligament space widening of teeth and osteolysis of bone at muscular attachments. The oral and maxillofacial manifestations significantly contribute to its disease burden and are often overlooked and undertreated as their treatment can be limited due to their challenging rheumatological care. Given the complexity of the condition and its multisystemic impacts, better co-operation between dentists and rheumatologists may help improve this patient cohort's quality of life. This clinical article aims to better equip dentists to identify features of scleroderma and manage the day-to-day oro-facial manifestations.
Identifiants
pubmed: 38877249
doi: 10.1038/s41415-024-7453-1
pii: 10.1038/s41415-024-7453-1
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
881-886Informations de copyright
© 2024. The Author(s), under exclusive licence to the British Dental Association.
Références
Abbot S, Bossingham D, Proudman S, de Costa C, Ho-Huynh A. Risk factors for the development of systemic sclerosis: a systematic review of the literature. Rheumatol Adv Pract 2018; 2: 41.
Scleroderma and Raynaud's UK. Understanding Scleroderma. 2021. Available at https://www.sruk.co.uk/scleroderma/understanding-scleroderma/ (accessed September 2023).
Auluck A. Widening of periodontal ligament space and mandibular resorption in patients with systemic sclerosis. Dentomaxillofac Radiol 2007; 36: 441-442.
Careta M F, Romiti R. Localized scleroderma: clinical spectrum and therapeutic update. An Bras Dermatol 2015; 90: 62-73.
Bin Ahmad M Z, Mat Nasir N, Md Yasin M, Yusof A N M, Bakrin I H, Lim S C. A Case of Linear Scleroderma in a Young Child: A Diagnosis Easily Missed in Primary Care. Am J Case Rep 2023; 24: 940148.
Bobeica C, Niculet E, Craescu M et al. CREST Syndrome in Systemic Sclerosis Patients - Is Dystrophic Calcinosis a Key Element to a Positive Diagnosis? J Inflamm Res 2022; 15: 3387-3394.
Albilia J B, Lam D K, Blanas N, Clokie C M, Sándor G K. Small mouths…Big problems? A review of scleroderma and its oral health implications. J Can Dent Assoc 2007; 73: 831-836.
Sobolewski P, Maślińska M, Wieczorek M et al. Systemic sclerosis - multidisciplinary disease: clinical features and treatment. Reumatologia 2019; 57: 221-233.
Leader D M. Scleroderma and dentistry: every dentist is a scleroderma specialist. J Mass Dent Soc 2007; 56: 16-19.
Saeed K, Kumar N. Scleroderma and its oral implications. Dent Update 2022; 49: 834-838.
Balbir-Gurman A, Braun-Moscovici Y. Scleroderma overlap syndrome. Isr Med Assoc J 2011; 13: 14-20.
Cao Y, Kan H, Ma X, Zhang Y, Huang J, Long X. Autologous fat or adipose-derived stem cell grafting in systemic sclerosis treatment: a systematic review and meta-analysis. Clin Exp Rheumatol 2023; 41: 1659-1669.
Abdouh I, Porter S, Fedele S, Elgendy N, Ni Riordain R. Web-based information on the treatment of the mouth in systemic sclerosis. BMC Rheumatol 2020; 4: 61.
Neville B, Damm D, Allen C, Bouquot J. Oral and Maxillofacial Pathology. 4th ed. St Louis: Elsevier, 2015.
Vitali C, Baldanzi C, Polini F, Montesano A, Ammenti P, Cattaneo D. Instrumented Assessment of Oral Motor Function in Healthy Subjects and People with Systemic Sclerosis. Dysphagia 2015;30: 286-295.
Paquette D, Falanga V. Cutaneous concerns of scleroderma patients. J Dermatol 2003; 30: 438-443.
Alantar A, Cabane J, Hachulla E et al. Recommendations for the care of oral involvement in patients with systemic sclerosis. Arthritis Care Res 2011; 63: 1126-1133.
Baron M, Hudson M, Tatibouet S et al. The Canadian systemic sclerosis oral health study: orofacial manifestations and oral health-related quality of life in systemic sclerosis compared with the general population. Rheumatology 2014; 53: 1386-1394.
Poole J L, Brewer C, Rossie K, Good C C, Conte C, Steen V. Factors related to oral hygiene in persons with scleroderma. Int J Dent Hyg 2005; 3: 13-17.
Yuen H K, Weng Y, Reed S G, Summerlin L M, Silver R M. Factors associated with gingival inflammation among adults with systemic sclerosis. Int J Dent Hyg 2014; 12: 55-61.
Scardina G A, Pizzigatti M E, Messina P. Periodontal microcirculatory abnormalities in patients with systemic sclerosis. J Periodontol 2005; 76: 1991-1995.
Ozcelik O, Haytac M C, Ergin M, Antmen B, Seydaoglu G. The immunohistochemical analysis of vascular endothelial growth factors A and C and microvessel density in gingival tissues of systemic sclerosis patients: their possible effects on gingival inflammation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 105: 481-485.
Avouac J, Sordet C, Depinay C et al. Systemic sclerosis-associated Sjögren's syndrome and relationship to the limited cutaneous subtype: Results of a prospective study of sicca syndrome in 133 consecutive patients. Arthritis Rheum 2006; 54: 2243-2249.
Kobak S, Oksel F, Aksu K, Kabasakal Y. The frequency of sicca symptoms and Sjögren's syndrome in patients with systemic sclerosis. Int J Rheum Dis 2013; 16: 88-92.
Avouac J, Airò P, Dieude P et al. Associated autoimmune diseases in systemic sclerosis define a subset of patients with milder disease: results from 2 large cohorts of European Caucasian patients. J Rheumatol 2010; 37: 608-614.
Porter S R, Scully C, Hegarty A M. An update of the etiology and management of xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol 2004; 97: 28-46.
Scleroderma and Raynaud's UK. Oral and Dental. 2021. Available at https://www.sruk.co.uk/scleroderma/scleroderma-and-your-body/oral-and-dental/ (accessed January 2024).
Salliot C, Mouthon L, Ardizzone M. Sjogren's syndrome is associated with and not secondary to systemic sclerosis. Rheumatology 2007; 46: 321-326.
Porter S R, Leao J C. Review article: oral ulcers and its relevance to systemic disorders. Aliment Pharmacol Ther 2005; 21: 295-306.
Derk C T, Rasheed M, Spiegel J R, Jimenez S A. Increased incidence of carcinoma of the tongue in patients with systemic sclerosis. J Rheumatol 2005; 32: 637-641.
Onishi A, Sugiyama D, Kumagai S, Morinobu A. Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies. Arthritis Rheum 2013; 65: 1913-1921.
Derk C T, Rasheed M, Artlett C M, Jimenez S A. A cohort study of cancer incidence in systemic sclerosis. J Rheumatol 2006; 33: 1113-1116.
Vettori S, Staibano S, Mascolo M, Ilardi G, Valentini G. Non-Hodgkin's lymphoma in systemic sclerosis: case and literature review. Clin Rheumatol 2010; 29: 1-6.
Singh A G, Singh S, Matteson E L. Rate, risk factors and causes of mortality in patients with Sjogren's syndrome: a systematic review and meta-analysis of cohort studies. Rheumatology 2016; 55: 450-460.
Stafne E C, Austin L T. A characteristic dental finding in acrosclerosis and diffuse scleroderma. Am J Orthod Oral Surg 1944; 30: 25-29.
White S C, Frey N W, Blaschke D D et al. Oral radiographic changes in patients with progressive systemic sclerosis (scleroderma). J Am Dent Assoc 1977; 94: 1178-1182.
Mehra A. Periodontal space widening in patients with systemic sclerosis: a probable explanation. Dentomaxillofac Radiol 2008; 37: 183-184.
Vincent C, Agard C, Barbarot S et al. Orofacial manifestations of systemic sclerosis: A study of 30 consecutive patients. Rev Med Interne 2009; 30: 5-11.
Auluck A, Pai K M, Shetty C, Shenoi S D. Mandibular resorption in progressive systemic sclerosis: a report of three cases. Dentomaxillofac Radiol 2005; 34: 384-386.
Mallya S, Lam E. White and Pharoah's Oral Radiology - Principles and Interpretation. 8th ed. Saint Louis: Mosby, 2018.
Pogrel M A. Unilateral osteolysis of the mandibular angle and coronoid process in scleroderma. Int J Oral Maxillofac Surg 1988; 17: 155-156.
Seifert M H, Steigerwald J C, Cliff M M. Bone resorption of the mandible in progressive systemic sclerosis. Arthritis Rheum 1975; 18: 507-512.
Matsuda S, Memida T, Mizuno N et al. Reparative bone-like tissue formation in the tooth of a systemic sclerosis patient. Int Endod J 2018; 51: 1059-1066.
Arroyo-Bote S, Bucchi C, Manzanares M. External cervical resorption: a new oral manifestation of systemic sclerosis. J Endod 2017; 43: 1740-1743.
Yuen H K, Marlow N N, Reed S G et al. Effect of orofacial exercises on oral aperture in adults with systemic sclerosis. Disabil Rehabil 2012; 34: 84-89.
Kwakkenbos L, Delisle V C, Fox R S et al. Psychosocial aspects of scleroderma. Rheum Dis Clin North Am 2015; 41: 519-528.
Suarez-Almazor M E, Kallen M A, Roundtree A K, Mayes M. Disease and symptom burden in systemic sclerosis: a patient perspective. J Rhuematol 2007; 34: 1718-1726.
Thombs B D, Taillefer S S, Hudson M, Baron M. Depression in patients with systemic sclerosis: a systematic review of the evidence. Arthritis Rheum 2007; 57: 1089-1097.
Van Leeuwen N M, Ciaffi J, Liem S I E, Huizinga T W J, de Vries-Bouwstra J K. Health-related quality of life in patients with systemic sclerosis: evolution over time and main determinants. Rheumatol 2021; 60: 3646-3655.
Abdouh I, Porter S, Fedele S et al. Measuring the impact of systemic sclerosis on oral health-related quality of life in a UK population. J Oral Pathol Med 2021; 50: 812-819.